Literature DB >> 26144338

Incidence and Predictors for Ipsilateral Hydronephrosis Following Ureteroscopic Lithotripsy.

Meredith L Barbour1, Jay D Raman2.   

Abstract

OBJECTIVE: To review our experience in using ureteroscopy (URS) with lithotripsy for renal or ureteral calculi to determine the incidence and predictors of postprocedural ipsilateral hydronephrosis. PATIENTS AND METHODS: Records of 324 URS cases for renal or ureteral calculi with imaging performed 4-12 weeks postprocedure were reviewed. Ipsilateral hydronephrosis was determined by computed tomography scan or renal ultrasound. Univariate and multivariate analyses determined the factors associated with hydronephrosis.
RESULTS: 176 men and 148 women with a median age of 50 years were included. Median stone size was 6 mm and operative duration was 60 minutes; 30% of patients had multiple calculi; and 35% had undergone a prior ipsilateral URS. Overall, 49 of 324 patients (15%) had evidence of hydronephrosis, with 65% of these patients having symptoms and 40% requiring ancillary procedures. On multivariate analysis, increasing stone diameter (odds ratio [OR] 8.9, 95% confidence interval [CI] 1.9-23.8, P = .03), prior ipsilateral URS (OR 7.7, 95% CI 1.8-28.2, P = .006), longer operative duration (OR 6.5, 95% CI 1.8-16.3, P = .02), and renal colic symptoms (OR 48.3, 95% CI 14.7-71.4, P <.001) independently predicted hydronephrosis. Conversely, other factors including stone impaction at procedure, ureteral dilation, use of an access sheath, intraoperative perforation, or use of a stent did not associate with ipsilateral hydronephrosis.
CONCLUSION: In this contemporary cohort study, 15% of patients undergoing URS had evidence of ipsilateral hydronephrosis. Larger stone size, longer OR duration, prior ipsilateral URS, and recurrent colic were associated with an increased likelihood for this observation. Patients and stone cases with such characteristics likely warrant imaging modalities beyond plain radiography.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26144338     DOI: 10.1016/j.urology.2015.06.016

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Evaluation of postoperative hydronephrosis following semirigid ureteroscopy: Incidence and predictors.

Authors:  Mehmet İlker Gökçe; Barış Esen; Başak Gülpınar; Adil Hüseynov; Mete Özkidik; Evren Süer
Journal:  Turk J Urol       Date:  2017-05-03

2.  Low dose lignocaine + butorphanol vs. low dose bupivacaine for spinal anaesthesia in day care urological surgeries: a prospective randomized control trial.

Authors:  Shahil Rameshbhai Khant; Rajeev Chaudhari; Rishikesh Arun Kore; Shirish Bhagwat; Ranjan Purushottam Jakhalekar
Journal:  Turk J Urol       Date:  2017-05-03

3.  Suctioning semirigid ureteroscopic lithotomy versus minimally invasive percutaneous nephrolithotomy for large upper ureteral stones: a retrospective study.

Authors:  Hequn Chen; Zewu Zhu; Yu Cui; Yang Li; Zhiyong Chen; Zhongqing Yang; Feng Zeng
Journal:  Transl Androl Urol       Date:  2021-03

Review 4.  Does ureteral access sheath have an impact on ureteral injury?

Authors:  Mehmet Kazim Asutay; Marco Lattarulo; Despoina Liourdi; Abdulrahman Mohamed Al-Aown; Konstantinos Pagonis; Noor Nedal; Amelia Pietropaolo; Esteban Emiliani; Evangelos Liatsikos; Panagiotis Kallidonis
Journal:  Urol Ann       Date:  2022-01-20

5.  Ureterorenoscopic (URS) Lithotripsy and Balloon Dilation Cause Acute Kidney Injury and Distal Renal Tubule Damage: A Prospective Study.

Authors:  Ho-Shiang Huang; Ze-Hong Lu; Chan-Jung Liu
Journal:  Biomed Res Int       Date:  2022-09-14       Impact factor: 3.246

6.  Clinical factors associated with postoperative hydronephrosis after ureteroscopic lithotripsy.

Authors:  Sun Woo Kim; Ji Hoon Ahn; Sang Un Yim; Yang Hyun Cho; Bo Sung Shin; Ho Seok Chung; Eu Chang Hwang; Ho Song Yu; Kyung Jin Oh; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park
Journal:  Investig Clin Urol       Date:  2016-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.